DGAP-News: Apricus Biosciences and Abbott Sign Exclusive Agreement to Market Vitaros(R) (Alprostadil) in Canada
Apricus Biosciences, Inc.
09.01.2012 18:29
—————————————————————————
SAN DIEGO, 2012-01-09 18:29 CET (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio–) (Nasdaq:APRI)
(http://www.apricusbio.com) announced today that it has entered into an
exclusive licensing agreement granting Abbott Laboratories Limited a global,
diversified healthcare company, the exclusive rights to market Vitaros(r)
(alprostadil), Apricus Bio–s treatment for e
